Immunotherapy Clinical Trials in Shanghai, Shanghai Municipality
15 recruitingShanghai, Shanghai Municipality, China
Showing 1–15 of 15 trials
Recruiting
Establishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment
RadiotherapyImmunotherapySmall Cell Lung Cancer ( SCLC )+1 more
Shanghai Chest Hospital500 enrolled1 locationNCT07565532
Recruiting
Phase 2
The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
NSCLCImmunotherapyStereotactic Body Radiation Therapy (SBRT)
Fudan University27 enrolled1 locationNCT06738160
Recruiting
Phase 3
TDLN-sparing RT Plus Immunotherapy and Chemotherapy in Locally Advanced ESCC
Esophageal CarcinomaRadiotherapyImmunotherapy
Fudan University432 enrolled1 locationNCT06676449
Recruiting
Phase 2
Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer
Ovarian CancerImmunotherapyPembrolizumab
Obstetrics & Gynecology Hospital of Fudan University20 enrolled1 locationNCT07261683
Recruiting
Early Phase 1
A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)
Treatment Side EffectsEffects of ImmunotherapyAdvanced Gynecologic Tumors+1 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05098171
Recruiting
Early Phase 1
A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)
Treatment Side EffectsEffects of ImmunotherapyTumor Infiltrating Lymphocyte+2 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05098197
Recruiting
Association of Psychological Distress in Patients With Lung Cancer
Lung NeoplasmsPsychological DistressImmunotherapy+3 more
Shanghai Chest Hospital500 enrolled1 locationNCT06218901
Recruiting
Phase 2
Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Advanced Colorectal CarcinomaImmunotherapy
Fudan University208 enrolled10 locationsNCT06521866
Recruiting
Phase 2
A Study of Cadonilimab（AK104） Plus Lenvatinib in Previous Immunotherapy Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
RenJi Hospital28 enrolled1 locationNCT06035224
Recruiting
The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer
Carcinoma, Non-Small Cell LungPET/CTNeoadjuvant Immunotherapy
Ruijin Hospital30 enrolled1 locationNCT06623487
Recruiting
68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
Lung CarcinomaPET/CTImmunotherapy
Ruijin Hospital30 enrolled1 locationNCT06608160
Recruiting
Not Applicable
Toripalimab Combined With Definitive CCRT for LACC Patients
Cervical CancerImmunotherapyChemoradiotherapy
Ruijin Hospital150 enrolled1 locationNCT06256224
Recruiting
Phase 2
Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
Cervical CancerNeoadjuvant ImmunotherapyFertility-sparing Surgery
Xiaohua Wu30 enrolled1 locationNCT06209294
Recruiting
Phase 2
Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma
Esophageal Squamous Cell CarcinomaAdjuvant TherapyNeoadjuvant Chemoimmunotherapy
Guo Xufeng73 enrolled1 locationNCT06056336
Recruiting
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell CarcinomaNeoadjuvant Chemoimmunotherapy
Shanghai Zhongshan Hospital40 enrolled1 locationNCT05740995